In this episode of From Concept to Medicine, we dive into the story of Celecoxib, the first blockbuster COX-2 selective NSAID, widely known by its brand name Celebrex. Designed to relieve pain and inflammation with fewer gastrointestinal side effects than traditional NSAIDs, Celecoxib emerged from decades of pharmaceutical research seeking the elusive “safer NSAID.” We explore how it fits into the broader evolution of pain relief—from aspirin to ibuprofen to diclofenac—and trace its development as a response to growing awareness of GI risks tied to earlier anti-inflammatories. Along the way, we unpack the science of COX enzymes, showing how selectively targeting COX-2 was meant to offer therapeutic benefits without collateral damage to the stomach lining.

But the road to market wasn’t entirely smoo ...